These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 16814900)
1. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice. Brouwer CP; Bogaards SJ; Wulferink M; Velders MP; Welling MM Peptides; 2006 Nov; 27(11):2585-91. PubMed ID: 16814900 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of synthetic antibacterial oligopeptides based on the insect defensins on Methicillin-resistant Staphylococcus aureus in mice. Saido-Sakanaka H; Ishibashi J; Momotani E; Yamakawa M Dev Comp Immunol; 2005; 29(5):469-77. PubMed ID: 15707667 [TBL] [Abstract][Full Text] [Related]
3. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. Pag U; Oedenkoven M; Sass V; Shai Y; Shamova O; Antcheva N; Tossi A; Sahl HG J Antimicrob Chemother; 2008 Feb; 61(2):341-52. PubMed ID: 18174202 [TBL] [Abstract][Full Text] [Related]
4. Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. Cirioni O; Silvestri C; Ghiselli R; Giacometti A; Orlando F; Mocchegiani F; Chiodi L; Vittoria AD; Saba V; Scalise G Peptides; 2006 Nov; 27(11):2600-6. PubMed ID: 16797106 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica. Brown PD; Ngeno C Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064 [TBL] [Abstract][Full Text] [Related]
7. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells. Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890 [TBL] [Abstract][Full Text] [Related]
9. Discovery and development of a synthetic peptide derived from lactoferrin for clinical use. Brouwer CP; Rahman M; Welling MM Peptides; 2011 Sep; 32(9):1953-63. PubMed ID: 21827807 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. MacKenzie FM; Bruce J; Struelens MJ; Goossens H; Mollison J; Gould IM; Clin Microbiol Infect; 2007 Mar; 13(3):269-76. PubMed ID: 17391381 [TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus. Madhuri ; Shireen T; Venugopal SK; Ghosh D; Gadepalli R; Dhawan B; Mukhopadhyay K Peptides; 2009 Sep; 30(9):1627-35. PubMed ID: 19560499 [TBL] [Abstract][Full Text] [Related]
13. In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model. Faber C; Hoogendoorn RJ; Stallmann HP; Lyaruu DM; van Nieuw Amerongen A; Wuisman PI; J Antimicrob Chemother; 2004 Dec; 54(6):1078-84. PubMed ID: 15537700 [TBL] [Abstract][Full Text] [Related]
14. Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives. Fitzgerald-Hughes D; Devocelle M; Humphreys H FEMS Immunol Med Microbiol; 2012 Aug; 65(3):399-412. PubMed ID: 22409572 [TBL] [Abstract][Full Text] [Related]
15. Directed alteration of a novel bovine beta-defensin to improve antimicrobial efficacy against methicillin-resistant Staphylococcus aureus (MRSA). Meade KG; Cahalane S; Narciandi F; Cormican P; Lloyd AT; O'Farrelly C Int J Antimicrob Agents; 2008 Nov; 32(5):392-7. PubMed ID: 18775651 [TBL] [Abstract][Full Text] [Related]
16. Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivo. Welling MM; Brouwer CP; van 't Hof W; Veerman EC; Amerongen AV Antimicrob Agents Chemother; 2007 Sep; 51(9):3416-9. PubMed ID: 17620386 [TBL] [Abstract][Full Text] [Related]
17. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. Conlon JM; Galadari S; Raza H; Condamine E Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256 [TBL] [Abstract][Full Text] [Related]
18. A novel family of antimicrobial peptides from the skin of Amolops loloensis. Wang A; Wang J; Hong J; Feng H; Yang H; Yu X; Ma Y; Lai R Biochimie; 2008 Jun; 90(6):863-7. PubMed ID: 18312859 [TBL] [Abstract][Full Text] [Related]
19. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Phillips S; MacDougall C; Holdford DA Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425 [TBL] [Abstract][Full Text] [Related]
20. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity. Nan YH; Bang JK; Shin SY Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]